DJIA 15,346.97 -7.43 -0.05%
NASDAQ 3,496.46 -2.51 -0.07%
S&P 500 1,667.18 -0.29 -0.02%

44.98 -0.03 (-0.07%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CRL $44.98 -0.07%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $44.94
Previous Close $45.01
Daily Range $44.83 - $45.28
52-Week Range $31.48 - $46.90
Market Cap $2.2B
P/E Ratio 21.54
Dividend (Yield) $0.00 (0.0%)
Volume 108,510
Average Daily Volume 507,387
Current FY EPS $2.81

Sector

Healthcare

Industry

Drugs

Charles River Laboratories (CRL) Description

Charles River supports early-stage drug development with a “research models” business that breeds lab rats and “preclinical services” that run clinical trials for pharma and biotech companies. Website: http://www.criver.com/

News & Commentary

Cramer's Mad Money - 3 Things Driving The Market Higher (5/13/13)

Cramer's 'Mad Money' Recap: A Surreal Market

The Danger of Chasing This IPO's Profits

The largest contract research organization is back on the market

ABCO Posts Solid 4Q and FY2013 Earnings - Analyst Blog

Charles River Laboratories to Present at Baird’s Growth Stock Conference

Cramer: Big Pharma Has Lost Its Way

Cramer's Mad Money - The Most Important Game Changer For 2013 (5/2/13)

Cramer's Top Stock Picks: AGN BP CRL PRU AIG

Charles River Laboratories International Management Discusses Q1 2013 Results - Earnings Call Transc

Charles River Laboratories International Management Discusses Q1 2013 Results - Earnings Call Transcript

Charles River Misses Estimates in 1Q - Analyst Blog

See More CRL News...

CRL's Top Competitors

CRL $44.98 (-0.07%)
Current stock: CRL
ILMN $73.56 (2.17%)
Current stock: ILMN
LIFE $73.58 (0.05%)
Current stock: LIFE
WAT $97.88 (-0.12%)
Current stock: WAT